Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle
Tóm tắt
Neuronal activity within the central nervous system (CNS) strictly depends on homeostasis and therefore does not tolerate uncontrolled entry of blood components. It has been generally believed that under normal conditions, the endothelial blood-brain barrier (BBB) and the epithelial blood-cerebrospinal fluid barrier (BCSFB) prevent immune cell entry into the CNS. This view has recently changed when it was realized that activated T cells are able to breach the BBB and the BCSFB to perform immune surveillance of the CNS. Here we propose that the immune privilege of the CNS is established by the specific morphological architecture of its borders resembling that of a medieval castle. The BBB and the BCSFB serve as the outer walls of the castle, which can be breached by activated immune cells serving as messengers for outside dangers. Having crossed the BBB or the BCSFB they reach the castle moat, namely the cerebrospinal fluid (CSF)-drained leptomeningeal and perivascular spaces of the CNS. Next to the CNS parenchyma, the castle moat is bordered by a second wall, the glia limitans, composed of astrocytic foot processes and a parenchymal basement membrane. Inside the castle, that is the CNS parenchyma proper, the royal family of sensitive neurons resides with their servants, the glial cells. Within the CSF-drained castle moat, macrophages serve as guards collecting all the information from within the castle, which they can present to the immune-surveying T cells. If in their communication with the castle moat macrophages, T cells recognize their specific antigen and see that the royal family is in danger, they will become activated and by opening doors in the outer wall of the castle allow the entry of additional immune cells into the castle moat. From there, immune cells may breach the inner castle wall with the aim to defend the castle inhabitants by eliminating the invading enemy. If the immune response by unknown mechanisms turns against self, that is the castle inhabitants, this may allow for continuous entry of immune cells into the castle and lead to the death of the castle inhabitants, and finally members of the royal family, the neurons. This review will summarize the molecular traffic signals known to allow immune cells to breach the outer and inner walls of the CNS castle moat and will highlight the importance of the CSF-drained castle moat in maintaining immune surveillance and in mounting immune responses in the CNS.
Tài liệu tham khảo
Barker CF, Billingham RE: Immunologically priviledged sites. Adv Immunol. 1977, 25: 1-54. 10.1016/S0065-2776(08)60930-X.
Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to anterior chamber of the eye. Br J Exp Pathol. 1948, 29: 58-69.
Engelhardt B, Ransohoff RM: The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005, 26: 485-495. 10.1016/j.it.2005.07.004.
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ: Structure and function of the blood-brain barrier. Neurobiol Dis. 2010, 37: 13-25. 10.1016/j.nbd.2009.07.030.
Pardridge WM: Blood-brain barrier delivery. Drug Discov Today. 2007, 12: 54-61. 10.1016/j.drudis.2006.10.013.
Betz LA, Goldstein GW, Katzman R: Blood-Brain-Cerebrospinal Fluid Barriers. Basic Neurochemistry: Molecular, cellular, and medical aspects. Volume. Edited by: Siegel GJ. 1989, New York: Raven Press, 591-606. 4
Engelhardt B: The choroid plexus in health and disease. 2001, New York: Wiley-Liss
Engelhardt B, Wolburg-Buchholz K, Wolburg H: Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech. 2001, 52: 112-129. 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5.
Engelhardt B, Sorokin L: The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009, 31: 497-511. 10.1007/s00281-009-0177-0.
Krueger M, Bechmann I: CNS pericytes: concepts, misconceptions, and a way out. Glia. 2010, 58: 1-10. 10.1002/glia.20898.
Lindahl P, Johansson BR, Leveen P, Betsholtz C: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997, 277: 242-245. 10.1126/science.277.5323.242.
Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM: Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol. 2001, 153: 933-946. 10.1083/jcb.153.5.933.
Owens T, Bechmann I, Engelhardt B: Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol. 2008, 67: 1113-1121. 10.1097/NEN.0b013e31818f9ca8.
Hickey WF, Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 1988, 239: 290-292. 10.1126/science.3276004.
Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B: Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med. 2005, 11: 328-334. 10.1038/nm1197.
Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH, Weller RO: Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol. 2008, 34: 131-144. 10.1111/j.1365-2990.2007.00926.x.
Allt G, Lawrenson JG: Is the pial microvessel a good model for blood-brain barrier studies?. Brain Res Brain Res Rev. 1997, 24: 67-76. 10.1016/S0165-0173(97)00011-8.
Bär T: The vascular system of the cerebral cortex. Adv Anat Embryol Cell Biol. 1980, 59: 1-62.
Barkalow FJ, Goodman MJ, Gerritsen ME, Mayadas TN: Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. Blood. 1996, 88: 4585-4593.
Yong T, Zheng MQ, Linthicum DS: Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J Neuroimmunol. 1997, 80: 158-164. 10.1016/S0165-5728(97)00151-3.
Sospedra M, Martin R: Immunology of multiple sclerosis. Annu Rev Immunol. 2005, 23: 683-747. 10.1146/annurev.immunol.23.021704.115707.
Ben-Nun A, Wekerle H, Cohen I: The rapid isolation of clonable antigen-specific T cell lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol. 1981, 11: 195-10.1002/eji.1830110307.
Vajkoczy P, Laschinger M, Engelhardt B: Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest. 2001, 108: 557-565.
Laschinger M, Vajkoczy P, Engelhardt B: Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur J Immunol. 2002, 32: 3598-3606. 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6.
Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ: Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. J Neuroimmunol. 2003, 142: 47-57. 10.1016/S0165-5728(03)00258-3.
Carrithers MD, Visintin I, Kang SJ, Janeway CA: Differential adhesion molecule requirements for immune surveillance and inflammatory recruiment. Brain. 2000, 123: 1092-1101. 10.1093/brain/123.6.1092.
Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD: Leukocyte rolling and extravasation are severely compromised in P selectin -deficient mice. Cell. 1993, 74: 541-554. 10.1016/0092-8674(93)80055-J.
Doring A, Wild M, Vestweber D, Deutsch U, Engelhardt B: E- and P-Selectin Are Not Required for the Development of Experimental Autoimmune Encephalomyelitis in C57BL/6 and SJL Mice. J Immunol. 2007, 179: 8470-8479.
Bartholomaus I, Kawakami N, Odoardi F, Schlager C, Miljkovic D, Ellwart JW, Klinkert WE, Flugel-Koch C, Issekutz TB, Wekerle H, Flugel A: Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature. 2009, 462: 94-98. 10.1038/nature08478.
Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H: Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity. 2001, 14: 547-560. 10.1016/S1074-7613(01)00143-1.
Kivisakk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu L, Baekkevold ES, Lassmann H, Staugaitis SM: Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA. 2005, 100: 8389-8394. 10.1073/pnas.1433000100. Epub 2003 Jun 8326
Ransohoff RM, Kivisakk P, Kidd G: Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol. 2003, 3: 569-581. 10.1038/nri1130.
Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F: C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009, 10: 514-523. 10.1038/ni.1716.
Steffen BJ, Breier G, Butcher EC, Schulz M, Engelhardt B: ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol. 1996, 148: 1819-1838.
Wolburg K, Gerhardt H, Schulz M, Wolburg H, Engelhardt B: Ultrastructural localization of adhesion molecules in the healthy and inflamed choroid plexus of the mouse. Cell Tissue Res. 1999, 296: 259-269. 10.1007/s004410051287.
Piccio L, Rossi B, Scarpini E, Laudanna C, Giagulli C, Issekutz AC, Vestweber D, Butcher EC, Constantin G: Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J Immunol. 2002, 168: 1940-1949.
Kerfoot S, Kubes P: Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol. 2002, 169: 1000-1006.
Kerfoot SM, Norman MU, Lapointe BM, Bonder CS, Zbytnuik L, Kubes P: Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J Immunol. 2006, 176: 6225-6234.
Battistini L, Piccio L, Rossi B, Bach S, Galgani S, Gasperini C, Ottoboni L, Ciabini D, Caramia MD, Bernardi G: CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood. 2003, 101: 4775-4782. 10.1182/blood-2002-10-3309.
Engelhardt B, Vestweber D, Hallmann R, Schulz M: E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood. 1997, 90: 4459-4472.
Engelhardt B, Kempe B, Merfeld-Clauss S, Laschinger M, Furie B, Wild MK, Vestweber D: P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J Immunol. 2005, 175: 1267-1275.
Osmers I, Bullard DC, Barnum SR: PSGL-1 is not required for development of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2005, 166: 193-196. 10.1016/j.jneuroim.2005.06.001.
Bill R, Döring A, Deutsch U, Engelhardt B: PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice. J Neuroimmunol. 2010,
Coisne C, Mao W, Engelhardt B: Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. J Immunol. 2009, 182: 5909-5913. 10.4049/jimmunol.0803418.
Bauer M, Brakebusch C, Coisne C, Sixt M, Wekerle H, Engelhardt B, Fassler R: {beta}1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc Natl Acad Sci USA. 2009, 106: 1920-1925. 10.1073/pnas.0808909106.
Ubogu EE, Cossoy MB, Ransohoff RM: The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci. 2006, 27: 48-55. 10.1016/j.tips.2005.11.002.
Ransohoff RM, Tani M, Glabinski AR, Chernosky A, Krivacic K, Peterson JW, Chien HF, Trapp BD: Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocytochemical approaches. Meth Enzymol. 1997, 287: 319-348. full_text.
Alt C, Laschinger M, Engelhardt B: Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol. 2002, 32: 2133-2144. 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W.
Columba-Cabezas S, Serafini B, Ambrosini E, Aloisi F: Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 2003, 13: 38-51. 10.1111/j.1750-3639.2003.tb00005.x.
Krumbholz M, Theil D, Steinmeyer F, Cepok S, Hemmer B, Hofbauer M, Farina C, Derfuss T, Junker A, Arzberger T: CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J Neuroimmunol. 2007, 190: 72-79. 10.1016/j.jneuroim.2007.07.024.
McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS: CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol. 2006, 177: 8053-8064.
Cross AH, Cannella B, Brosnan CF, Raine CS: Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest. 1990, 63: 162-170.
Steffen BJ, Butcher EC, Engelhardt B: Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol. 1994, 145: 189-201.
Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA: Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993, 177: 57-68. 10.1084/jem.177.1.57.
Sobel RA, Mitchell ME, Fondren G: Intercellular Adhesion Molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol. 1990, 136: 1309-1316.
Bo L, Peterson JW, Mork S, Hoffman PA, Gallatin WM, Ransohoff RM, Trapp BD: Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Expl Neurol. 1996, 55: 1060-1072.
Cannella B, Raine CS: The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol. 1995, 37: 424-435. 10.1002/ana.410370404.
Peterson JW, Bo L, Mork S, Chang A, Ransohoff RM, Trapp BD: VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J Neuropathol Exp Neurol. 2002, 61: 539-546.
Man S, Tucky B, Bagheri N, Li X, Kochar R, Ransohoff RM: alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions. J Neuroimmunol. 2009, 210: 92-99. 10.1016/j.jneuroim.2009.03.008.
Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N: Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 1992, 356: 63-66. 10.1038/356063a0.
Laschinger M, Engelhardt B: Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J Neuroimmunol. 2000, 102: 32-43. 10.1016/S0165-5728(99)00156-3.
Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Dopp E, van der Meide PH, Dijkstra CD, De Vries HE: Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol. 2002, 127: 69-79. 10.1016/S0165-5728(02)00098-X.
Greenwood J, Wang Y, Calder VL: Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. Immunology. 1995, 86: 408-415.
Seguin R, Biernacki K, Rotondo RL, Prat A, Antel JP: Regulation and functional effects of monocyte migration across human brain-derived endothelial cells. J Neuropathol Exp Neurol. 2003, 62: 412-419.
Steiner O, Coisne C, Cecchelli R, Boscacci R, Deutsch U, Engelhardt B, Lyck R: Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J Immunol. 2010, 185: 4846-4855. 10.4049/jimmunol.0903732.
Engelhardt B, Laschinger M, Schulz M, Samulowitz U, Vestweber D, Hoch G: The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J Clin Invest. 1998, 102: 2096-2105. 10.1172/JCI4271.
Kent SJ, Karlik SJ, Cannon C, Hines DK, Yednock TA, Fritz LC, Horner HC: A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol. 1995, 58: 1-10. 10.1016/0165-5728(94)00165-K.
Keszthelyi E, Karlik S, Hyduk S, Rice GPA, Gordon G, Yednock T, Horner H: Evidence for a prolonged role of a4 integrin throughout active experimental allergic encephalomyelitis. Neurol. 1996, 47: 1053-1059.
Engelhardt B, Kappos L: Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener Dis. 2008, 5: 16-22. 10.1159/000109933.
Archelos JJ, Jung S, Maurer M, Schmied M, Lassmann H, Tamatani T, Miyasaka M, Toyka KV, Hartung HP: Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol. 1993, 34: 145-154. 10.1002/ana.410340209.
Bullard DC, Hu X, Schoeb TR, Collins RG, Beaudet AL, Barnum SR: Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J Immunol. 2007, 178: 851-857.
Cannella B, Cross AH, Raine CS: Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J Neuroimmunol. 1993, 46: 43-55. 10.1016/0165-5728(93)90232-N.
Greenwood J, Etienne-Manneville S, Adamson P, Couraud PO: Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol. 2002, 38: 315-322. 10.1016/S1537-1891(02)00199-4.
Greenwood J, Heasman SJ, Alvarez JI, Prat A, Lyck R, Engelhardt B: Leukocyte-endothelial cell crosstalk at the blood-brain barrier: A prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol. 2011, 37 (1): 24-39.
Lyck R, Reiss Y, Gerwin N, Greenwood J, Adamson P, Engelhardt B: T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood. 2003, 102: 3675-3683. 10.1182/blood-2003-02-0358.
Wolburg H, Wolburg-Buchholz K, Engelhardt B: Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol (Berl). 2005, 109: 181-190. 10.1007/s00401-004-0928-x.
Lossinski AS, Badmajew V, Robson JA, Moretz RC, Wisniewski HM: Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol. 1989, 78: 359-371. 10.1007/BF00688172.
Raine CS, Cannella B, Duijvestijn AM, Cross AH: Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest. 1990, 63: 476-489.
Wekerle H, Engelhardt B, Risau W, Meyermann R: Interaction of T lymphocytes with cerebral endothelial cells in vitro. Brain Pathol. 1991, 1: 107-114. 10.1111/j.1750-3639.1991.tb00647.x.
McMenamin PG, Forrester JV, Steptoe RJ, Dua HS: Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium. Lab Invest. 1992, 67: 42-55.
Greenwood J, Howes R, Lightman S: The blood-retinal barrier in experimental autoimmune uveoretinitis - leukocyte interactions and functional damage. Lab Invest. 1994, 70: 39-52.
Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle N, Engelhardt B, Madri JM: Changes in vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1 (CD31) deficient mice. J Clin Invest. 2002, 109: 383-392.
Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, Fruscella P, Adorini L, Martino G, Furlan R, De Simoni MG, Dejana E: Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med. 1999, 190: 1351-1356. 10.1084/jem.190.9.1351.
Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, Bouthillier A, Becher B, Arbour N, David S, Stanimirovic D, Prat A: Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol. 2008, 9: 137-145. 10.1038/ni1551.
Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E, Loser K, Beissert S, Georges-Labouesse E, Sorokin LM: Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med. 2009, 15: 519-527. 10.1038/nm.1957.
Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM: Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med. 2006, 203: 1007-1019. 10.1084/jem.20051342.